Can I Use Hormone Therapy? Understanding Who Qualifies, Who Needs a Tailored Approach, and Who Should Explore Alternatives
If you've ever Googled "am I a candidate for HRT" and walked away more confused than when you started, you're not alone. Between outdated fear-based messaging, conflicting advice from well-meaning providers, and a general lack of education around menopause, so many women have been left wondering if hormone therapy is even an option for them.
The short answer? For most women, it is.
One of the clearest ways to think about HRT candidacy is a red, yellow, and green light framework. It cuts through the noise and helps you understand where you might fall, and why the conversation with your provider matters so much.
Here is what each category looks like.
Green Light: Most Women Qualify
The green light category is exactly what it sounds like. If you are a generally healthy woman experiencing perimenopause or menopause symptoms, you are likely a strong candidate for hormone therapy. No major health history. No significant complicating factors. Just a body going through a hormonal transition that has real, treatable symptoms.
This is the category the majority of women fall into, yet so few ever get offered the conversation. If you have been dismissed, told to "just wait it out," or handed an antidepressant when what you really wanted was answers about your hormones, that is not a reflection of your candidacy. It is a reflection of how undertreated menopause has been for decades.
Hot flashes, night sweats, sleep disruption, brain fog, mood changes, joint pain, low libido, vaginal dryness. These are not things you have to white-knuckle through. If you are otherwise healthy, hormone therapy is a well-supported, evidence-based option worth a real conversation.
Yellow Light: Proceed Thoughtfully
A yellow light does not mean no. It means the conversation requires more nuance, and formulation and route of administration matter.
Yellow light situations include:
Migraine with aura. Oral estrogen can increase stroke risk in women who experience aura with their migraines. Transdermal estrogen, meaning a patch or gel applied to the skin, bypasses the liver and does not carry that same risk, making it a much safer route for many of these women.
Active smoker. Smoking already increases cardiovascular risk. Combined with oral estrogen, that risk is compounded. Transdermal delivery changes the picture significantly.
Autoimmune conditions. This requires a careful look at which condition, how well-managed it is, and what medications are already involved. HRT is not automatically off the table.
History of stroke. A past stroke does not categorically rule out hormone therapy, but it requires a thoughtful risk assessment and almost always points toward transdermal delivery rather than oral.
Clotting disorders. Oral estrogen increases clotting risk. Transdermal estrogen does not carry the same risk. For women with a known clotting disorder, route of administration is often the deciding factor.
Age over 60. Starting hormone therapy more than ten years after menopause does require more careful consideration, particularly around cardiovascular health. But it is not a hard stop. Healthy women over 60 with bothersome symptoms can still be candidates, especially at lower doses delivered transdermally.
The common thread in yellow light cases is this: formulation and delivery route can make a treatment that seems off-limits entirely reasonable. This is exactly why seeing a provider who understands the nuances of hormone therapy matters so much. A provider who only knows how to prescribe one way will see a yellow light and stop. A provider who understands the options will find a path forward.
Red Light: When Hormone Therapy May Not Be Safe
Red light situations are where hormone therapy, in its systemic form, may genuinely not be the safest option. These include:
Active or recent blood clot
Active liver disease
Unexplained vaginal bleeding
Uterine cancer
Recent stroke or cardiovascular event
Estrogen-receptor positive breast cancer
These are real contraindications that require serious attention. But here is something important: a red light does not mean no options. It means systemic hormone therapy may not be appropriate right now, and the conversation shifts toward what else can be done.
Local vaginal estrogen, for example, works in the tissue of the vagina and vulva with minimal systemic absorption and is considered safe in many situations where systemic estrogen is not. Non-hormonal treatments for hot flashes, sleep, and mood have also advanced significantly. A red light is not a door slamming shut. It is a reason to have a more specialized conversation.
Why This Framework Matters
For years, women have been told "no" without explanation. They left appointments without understanding why hormone therapy was not offered, or worse, without it ever being brought up. This framework exists to make that conversation clearer.
Most women are green. Some are yellow, and yellow has a path forward. Very few are truly red, and even red is not the end of the road.
If you have been wondering whether hormone therapy is an option for you, the answer is probably worth a real conversation with a knowledgeable provider. Not one who says no by default, but one who understands your full health history, knows the difference between oral and transdermal delivery, and is willing to think through your individual situation with you.
That is what midlife hormone care is supposed to look like.
Erin is a Women's Health Nurse Practitioner and Menopause Society Certified Practitioner at Evangeline Midlife in Bradenton, FL. She specializes in perimenopause and menopause hormone optimization for women throughout Florida.
